{"2501.01372": {"publish_time": "2025-01-02", "title": "ScarNet: A Novel Foundation Model for Automated Myocardial Scar Quantification from LGE in Cardiac MRI", "paper_summary": "Background: Late Gadolinium Enhancement (LGE) imaging is the gold standard\nfor assessing myocardial fibrosis and scarring, with left ventricular (LV) LGE\nextent predicting major adverse cardiac events (MACE). Despite its importance,\nroutine LGE-based LV scar quantification is hindered by labor-intensive manual\nsegmentation and inter-observer variability. Methods: We propose ScarNet, a\nhybrid model combining a transformer-based encoder from the Medical Segment\nAnything Model (MedSAM) with a convolution-based U-Net decoder, enhanced by\ntailored attention blocks. ScarNet was trained on 552 ischemic cardiomyopathy\npatients with expert segmentations of myocardial and scar boundaries and tested\non 184 separate patients. Results: ScarNet achieved robust scar segmentation in\n184 test patients, yielding a median Dice score of 0.912 (IQR: 0.863--0.944),\nsignificantly outperforming MedSAM (median Dice = 0.046, IQR: 0.043--0.047) and\nnnU-Net (median Dice = 0.638, IQR: 0.604--0.661). ScarNet demonstrated lower\nbias (-0.63%) and coefficient of variation (4.3%) compared to MedSAM (bias:\n-13.31%, CoV: 130.3%) and nnU-Net (bias: -2.46%, CoV: 20.3%). In Monte Carlo\nsimulations with noise perturbations, ScarNet achieved significantly higher\nscar Dice (0.892 \\pm 0.053, CoV = 5.9%) than MedSAM (0.048 \\pm 0.112, CoV =\n233.3%) and nnU-Net (0.615 \\pm 0.537, CoV = 28.7%). Conclusion: ScarNet\noutperformed MedSAM and nnU-Net in accurately segmenting myocardial and scar\nboundaries in LGE images. The model exhibited robust performance across diverse\nimage qualities and scar patterns.", "paper_summary_zh": "<paragraph>\u80cc\u666f\uff1a\u5ef6\u8fdf\u9486\u589e\u5f3a\uff08LGE\uff09\u6210\u50cf\u7528\u4e8e\u8bc4\u4f30\u5fc3\u808c\u7ea4\u7ef4\u5316\u548c\u7622\u75d5\u7684\u9ec4\u91d1\u6807\u51c6\uff0c\u5de6\u5fc3\u5ba4 (LV) LGE \u8303\u56f4\u9884\u6d4b\u91cd\u5927\u7684\u5fc3\u810f\u4e0d\u826f\u4e8b\u4ef6 (MACE)\u3002\u5c3d\u7ba1\u5176\u91cd\u8981\u6027\uff0c\u4f46\u57fa\u4e8e LGE \u7684\u5e38\u89c4 LV \u7622\u75d5\u91cf\u5316\u53d7\u5230\u52b3\u52a8\u5bc6\u96c6\u578b\u624b\u52a8\u5206\u5272\u548c\u89c2\u5bdf\u8005\u95f4\u5dee\u5f02\u7684\u963b\u788d\u3002\u65b9\u6cd5\uff1a\u6211\u4eec\u63d0\u51fa ScarNet\uff0c\u4e00\u79cd\u6df7\u5408\u6a21\u578b\uff0c\u5b83\u5c06\u6765\u81ea\u533b\u5b66\u5206\u5272\u4efb\u4f55\u6a21\u578b (MedSAM) \u7684\u57fa\u4e8e Transformer \u7684\u7f16\u7801\u5668\u4e0e\u57fa\u4e8e\u5377\u79ef\u7684 U-Net \u89e3\u7801\u5668\u76f8\u7ed3\u5408\uff0c\u5e76\u901a\u8fc7\u5b9a\u5236\u7684\u6ce8\u610f\u529b\u5757\u8fdb\u884c\u589e\u5f3a\u3002ScarNet \u5728 552 \u4f8b\u7f3a\u8840\u6027\u5fc3\u808c\u75c5\u60a3\u8005\u4e0a\u63a5\u53d7\u8bad\u7ec3\uff0c\u8fd9\u4e9b\u60a3\u8005\u7684\u5fc3\u808c\u548c\u7622\u75d5\u8fb9\u754c\u7531\u4e13\u5bb6\u5206\u5272\uff0c\u5e76\u5728 184 \u4f8b\u5355\u72ec\u60a3\u8005\u4e0a\u8fdb\u884c\u6d4b\u8bd5\u3002\u7ed3\u679c\uff1aScarNet \u5728 184 \u4f8b\u6d4b\u8bd5\u60a3\u8005\u4e2d\u5b9e\u73b0\u4e86\u7a33\u5065\u7684\u7622\u75d5\u5206\u5272\uff0c\u4ea7\u751f 0.912 \u7684\u4e2d\u503c Dice \u5f97\u5206\uff08IQR\uff1a0.863--0.944\uff09\uff0c\u660e\u663e\u4f18\u4e8e MedSAM\uff08\u4e2d\u503c Dice = 0.046\uff0cIQR\uff1a0.043--0.047\uff09\u548c nnU-Net\uff08\u4e2d\u503c Dice = 0.638\uff0cIQR\uff1a0.604--0.661\uff09\u3002\u4e0e MedSAM\uff08\u504f\u5dee\uff1a-13.31%\uff0cCoV\uff1a130.3%\uff09\u548c nnU-Net\uff08\u504f\u5dee\uff1a-2.46%\uff0cCoV\uff1a20.3%\uff09\u76f8\u6bd4\uff0cScarNet \u8868\u73b0\u51fa\u8f83\u4f4e\u7684\u504f\u5dee\uff08-0.63%\uff09\u548c\u53d8\u5f02\u7cfb\u6570\uff084.3%\uff09\u3002\u5728\u5e26\u6709\u566a\u58f0\u6270\u52a8\u7684\u8499\u7279\u5361\u7f57\u6a21\u62df\u4e2d\uff0cScarNet \u5b9e\u73b0\u4e86\u660e\u663e\u9ad8\u4e8e MedSAM\uff080.048 \u00b1 0.112\uff0cCoV = 233.3%\uff09\u548c nnU-Net\uff080.615 \u00b1 0.537\uff0cCoV = 28.7%\uff09\u7684\u7622\u75d5 Dice\uff080.892 \u00b1 0.053\uff0cCoV = 5.9%\uff09\u3002\u7ed3\u8bba\uff1aScarNet \u5728\u51c6\u786e\u5206\u5272 LGE \u56fe\u50cf\u4e2d\u7684\u5fc3\u808c\u548c\u7622\u75d5\u8fb9\u754c\u65b9\u9762\u4f18\u4e8e MedSAM \u548c nnU-Net\u3002\u8be5\u6a21\u578b\u5728\u4e0d\u540c\u7684\u56fe\u50cf\u8d28\u91cf\u548c\u7622\u75d5\u6a21\u5f0f\u4e0b\u8868\u73b0\u51fa\u7a33\u5065\u7684\u6027\u80fd\u3002</paragraph>", "author": "Neda Tavakoli et.al.", "authors": "Neda Tavakoli, Amir Ali Rahsepar, Brandon C. Benefield, Daming Shen, Santiago L\u00f3pez-Tapia, Florian Schiffers, Jeffrey J. Goldberger, Christine M. Albert, Edwin Wu, Aggelos K. Katsaggelos, Daniel C. Lee, Daniel Kim", "id": "2501.01372v1", "paper_url": "http://arxiv.org/abs/2501.01372v1", "repo": "null"}}